Sagimet Biosciences SGMT
NASDAQ SGMT
$9.37 -0.51 (-5.16%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sagimet Biosciences (SGMT) Cash from Financing Activities (2022 - 2025)

Updated

Sagimet Biosciences (SGMT) posted Cash from Financing Activities of $275,000 for FY2025, down 99.7% from $104.82 million in FY2024.

Analysis

Sagimet Biosciences (SGMT) Cash from Financing Activities (2022 - 2025) Analysis & Trends

Since FY2022, Sagimet Biosciences has reported Cash from Financing Activities for 4 years.

  • The FY2025 figure stands as the lowest annual Cash from Financing Activities since FY2022.
  • Business Quant data shows SGMT's Cash from Financing Activities at $104.82 million in FY2024 (+21.6%), $86.17 million in FY2023 and -$73,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Sagimet Biosciences 524.77 Mn 524.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 274,000.00
Jun 30, 2024 -27,000.00
Mar 31, 2024 104.85 Mn
Sep 30, 2023 87.21 Mn
Jun 30, 2023 -910,000.00
Mar 31, 2023 -136,000.00
Dec 31, 2022 -55,000.00
API Access

Sagimet Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SGMT&period=max&api_key=YOUR_API_KEY